Unger JW, Moss AM, Livingston JN
GLP-1 medications are a newer class of weight loss treatments
Double-check by holding the syringe at eye level and confirming the meniscus aligns with your target volume mark
Perspective: Cell danger response biology-The new science that connects environmental health with mitochondria and the rising tide of chronic illness
Summary Keywords intermittent fasting, precision medicine, anti-obesity pharmacotherapy, cardiovascular disease, genetics, GLP-1, GIP Citation Eliopoulos AG, Gkouskou KK, Tsioufis K and Sanoudou D (2025) A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy